He is also the Chief Financial Officer at voestalpine AG and a Member of the Supervisory Board at AMAG Austria Metall AG. Previously, he served as the Chief Executive Officer at AMAG Austria ...

What was a commonly known secret finally became official Wednesday when the Utah Hockey Club unveiled its new nickname, the Mammoth, and its logo. Last week, the Utah Mammoth name was shown on the ...

San Francisco architect Donald MacDonald received representatives of the team who were visiting on a reconnaissance mission. Although the eastern span’s stately tower with its single cable ...

For the first time in more than 20 years, Amazon’s logo got a touch-up. In fact, all of its logos got a touch-up. The small but subtle changes are part of a company-wide brand system refinement ...

"When it came to naming the team, we did something unprecedented—going through four rounds of community voting, including getting feedback not only on potential names but also on potential logos ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their research efforts around the adeno-associated virus (AAV) vectors used ...

After several rounds of fan voting, Mammoth was the winner, and the team unveiled new logos and jerseys on Wednesday. After moving from Arizona prior to the 2024-25 season, the team used the Utah ...

The franchise was officially created in April 2024, unveiling a temporary logo, name and color scheme by June 2024. Since then, the team has operated under the "Utah Hockey Club" name; now ...

Canadian Tire Corp. has expressed interest in purchasing Hudson’s Bay’s intellectual property, which may include its iconic stripes and logos, according to a source close to the beleaguered ...

voestalpine AG, as Member-Supervisory Board from 2004, BKS Bank AG, as Independent Member-Supervisory Board, Federation of Austrian Industry, as Member-Management Board, Mitterbauer Privatstiftung ...

The facility, which was previously used by Novartis to manufacture the gene therapy Zolgensma, was picked up by BMS in early 2023 to bolster viral vector capacity for its commercial cell therapy ...